In Phase 3 clinical trial for metastatic pancreatic ductal adenocarcinoma, a four-drug chemotherapy treatment led to a longer overall survival than a two-drug combination.
The source of tumour cell resistance to immunotherapy was identified by a recent study that examined the pancreatic cancer tumour microenvironment, and novel therapeutic approaches were developed as a result.
In the Phase 3 clinical trial for metastatic pancreatic ductal adenocarcinoma, a four-drug chemotherapy treatment led to a longer overall survival than a two-drug combination.
A molecular mechanism important for the development of pancreatic cancers has been found by researchers at the University of California, San Diego School of Medicine. The mechanism could possibly contribute to the disease's great resistance to treatment and proclivity for metastasis.
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells.
A randomised clinical trial has found that treating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery.
Cancer-causing gene mutation KRAS, found in nearly 30 per cent of all human tumours, successfully shrunk tumours or stopped cancer growth in preclinical models of pancreatic cancer.
Study revealed the possible cause of pancreatic cancer. The findings hold implications for the targeted treatment of pancreatic ductal adenocarcinoma (PDAC), which accounts for the vast majority of all pancreatic tumors and is the fourth-leading cause of cancer-related deaths worldwide.
He received a late-stage pancreatic cancer diagnosis in 2013 and was given 10 months to live. He chose not to receive treatment. Then, after his 'Game of Thrones' part was cut short, he embarked on a farewell tour and collaborated with Roger Daltrey to create a goodbye album in 2014. Late
Washington [US], October 22 (ANI): Biomedical engineers have demonstrated the most effective treatment for pancreatic cancer in mouse models ever recorded. While most mouse trials consider simply halting growth a success, the new treatment completely eliminated tumors in 80% of mice across s